Financials in USD. Standardized financial statements.
A compact view of how LifeTech Scientific Corporation turns revenue into operating income and net income.
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $1.30B | $1.27B | $1.10B | $925.33M | $642.30M | $668.88M | $556.70M | $409.13M | $352.85M | $311.61M |
| Revenue Growth? | +2.9% | +15.5% | +18.6% | +44.1% | -4.0% | +20.2% | +36.1% | +15.9% | +13.2% | 0.0% |
| Cost of Revenue? | $322.26M | $271.54M | $223.38M | $177.80M | $129.15M | $134.06M | $101.68M | $77.17M | $76.31M | $59.03M |
| Gross Profit? | $981.43M | $995.64M | $873.93M | $747.53M | $513.14M | $534.82M | $455.02M | $331.96M | $276.53M | $252.58M |
| Gross Margin? | +75.3% | +78.6% | +79.6% | +80.8% | +79.9% | +80.0% | +81.7% | +81.1% | +78.4% | +81.1% |
| Operating Expenses? | $795.10M | $612.36M | $497.99M | $420.86M | $248.66M | $412.86M | $337.43M | $144.89M | $175.84M | $159.69M |
| Operating Income? | $186.34M | $383.28M | $375.93M | $328.74M | $264.49M | $188.75M | $164.19M | $192.21M | $108.31M | $94.45M |
| EBITDA? | $288.88M | $253.46M | $445.78M | $397.59M | $314.14M | $246.22M | $200.03M | $211.45M | $120.10M | $82.34M |
| Income Before Tax | $199.00M | $175.58M | $378.05M | $332.93M | $242.62M | $170.81M | $167.19M | $193.62M | $186.95M | $26.40M |
| Income Tax Expense | $30.50M | $68.09M | $59.31M | $49.57M | $35.58M | $43.65M | $45.84M | $30.05M | $41.24M | $22.37M |
| Net Income? | $222.39M | $263.24M | $325.34M | $292.47M | $216.09M | $129.20M | $121.08M | $163.47M | $145.65M | $2.36M |
| EPS? | $0.05 | $0.06 | $0.08 | $0.07 | $0.05 | $0.03 | $0.03 | $0.04 | $0.04 | $0.00 |
| Diluted EPS? | $0.05 | $0.06 | $0.07 | $0.06 | $0.05 | $0.03 | $0.03 | $0.04 | $0.04 | $0.00 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality